Unicancer
Clara Guyonneau is a Clinical Project Manager in Oncology at Unicancer, responsible for setting up and conducting European and national clinical trials in oncology while adhering to ICH-GCP guidelines. Previous experience includes roles as a Clinical Project Manager at Inserm, managing extensive clinical trials across multiple countries, and as a Clinical Project Leader Junior at CERC, focusing on cardiovascular clinical trials. Clara's early career involved positions at ANSM, where evaluations and coordination of clinical trial authorizations were handled, and various roles in pharmacy and health services. Clara holds a Doctorate in Pharmacy from Paris-Sud University and a Master’s in Clinical Drug Development from Université de Caen Normandie.
This person is not in any teams
Unicancer
UNICANCER groups together the 20 French Comprehensive Cancer Centres (FCCCs) which are private, not-for-profit hospitals located across the French territory. FCCCs are dedicated to fighting cancer through a threefold mission of patient care, research and education. They contribute to the public hospital service in accordance with statutory fees, with no additional charge. UNICANCER is one of the largest cancer care and research organisations in Europe. Via its R&D department, it sponsors clinical trials to improve cancer patients’ care and access to innovation, particularly in areas neglected by the pharmaceutical industry. UNICANCER is accredited by the French Ministry of Health and is eligible for public grants. The French Comprehensive Cancer Centres in numbers: • 20 sites located throughout the French territory • 19,000 employees • >135,000 patients hospitalised each year • Approximately 500 active clinical trials • 17% of the patients treated are included in a clinical trial (vs an average of 8.5% of cancer patients in France) • 19 molecular biology platforms certified by the French National Cancer Institute • 7 integrated cancerology research sites (SIRIC) certified by the French NCI (out of 8) • 12 early-phase clinical trial Centres (CLIP²) certified by the French NCI (out of 16) • 5th for global publications in oncology • 32% of French publications in oncology (articles in which FCCCs have participated) UNICANCER sponsors • 76 ongoing clinical trials (2016) • Including 5400 patients (2016) • From 270 investigator sites (2015), • With 20% located in other European countries